7,929
Participants
Start Date
June 30, 2008
Primary Completion Date
January 31, 2010
Study Completion Date
April 30, 2010
All eligible subjects will provide blood for SEPT9 biomarker testing
A single blood sample per participant selected according to analysis plan is tested for evidence of methylation of a specific DNA sequence, SEPT9.
Regional Gastroenterology Associates of Lancaster, Ltd., Lancaster
University of Hamburg-Eppendorf, Hamburg
Charlottesville Medical Research, Charlottesville
Digestive Health Specialists, Winston-Salem
Southern Gastroenterology Associates, New Bern
Asheville Gastroenterology Associates PA, Asheville
Medical University of South Carolina Digestive Disease Center, Charleston
Atlanta Gastroenterology Associates, Atlanta
GI Care Center, Miami
Digestive Care, Boca Raton
Gastroenterology Center of the MidSouth, Germantown
Jackson Gastrointestinal Associates, Jackson
University of Louisville, Louisville
Heartland Medical Research, Inc., Clive
Minnesota Gastroenterology, Minneapolis
Rockford Gastroenterology Associates, Ltd., Rockford
The Portland Clinic, Portland
Northwest Gastroenterology Clinic, Portland
The Oregon Clinic, Portland
Northwest Gastroenterology Associates, Bellevue
Tacoma Digestive Disease Research Center, Tacoma
Berlin Private-Practice Gastroenterology Working Group, Berlin
Technical University of Munich, Munich
Lead Sponsor
Epigenomics, Inc
INDUSTRY